Repairing the cartilage protective layer to help osteoarthritis
Molecular Engineering of Cartilage PCM Mechanotransduction in Osteoarthritis Using Biomimetic Proteoglycans
Researchers are developing lab-made molecules that mimic cartilage sugars to rebuild the tiny protective layer around joint cells for people with osteoarthritis.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Villanova University NIH-funded |
| Lab location | 1 site (Villanova, United States) |
| Project ID | NIH-11136294 on NIH RePORTER |
What this research studies
This project makes biomimetic proteoglycans—lab-designed molecules that copy the sugar–protein structure of healthy cartilage—and applies them to damaged cartilage. Scientists will test these molecules in three-dimensional cartilage cell cultures and experimental models that mimic osteoarthritis to see if they restore the pericellular matrix, the small protective zone around each cartilage cell. Restoring that zone could help cells sense mechanical load normally and promote new cartilage matrix formation. The work combines chemistry, cell biology, and engineered tissue models to measure structural and functional recovery.
Who could benefit from this research
Good fit: People with osteoarthritis—especially those with early to moderate cartilage degeneration in a knee or other joint—would be the most relevant candidates for future clinical steps related to this work.
Not a fit: Patients with very advanced joint destruction or those already scheduled for immediate joint replacement are less likely to benefit from this approach.
Why it matters
Potential benefit: If successful, this approach could help rebuild damaged cartilage, reduce pain or slow osteoarthritis progression, and potentially delay or avoid joint replacement surgery.
How similar studies have performed: Early laboratory and animal work on PCM-targeting and biomimetic proteoglycans has shown promise in restoring matrix properties, but clinical benefits in people have not yet been demonstrated.
Where this research is happening
Villanova, United States
- Villanova University — Villanova, United States (Active)
Researchers
- Principal investigator: Marcolongo, Michele S — Villanova University
- Study coordinator: Marcolongo, Michele S
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.